SB 203580 (hydrochloride) is a pyridinyl imidazole inhibitor that displays a capacity to suppress proliferative activity on cytokine-activated lymphocytes. The same experiment has also shown that SB 203580 can inhibit the key cell cycle event of retinoblastoma protein phosphorylation in interleukin-2-stimulated T cells via inhibition of protein kinase B kinase. In addition, SB 203580, has been found to suppress the activation of mitogen-activated protein kinases (MAPKs). MAPKs have been found to regulate cell motility, differentiation, survival, and proliferation, therefore their inhibition can have a wide range of effects. We supply the SB203580 hydrochloride form.
1. Cuenda, A., et al. 1995. FEBS Lett. 364: 229-233. PMID: 7750577
2. Lali, F.V., et al. 2000. J. Biol. Chem. 275: 7395-7402. PMID: 10702313
3. Roux, P.P., et al. 2004. Microbiol. Mol. Biol. Rev. 68: 320-344. PMID: 15187187
Vedi quanti altri hanno usato SB 203580 (hydrochloride) (CAS 869185-85-3). Clicca sulla voce per laccesso a PubMed .
PMID: # 24988221 Hou, HH. et al. 2014. Autophagy. 10: 1509-21.
PMID: # 9013568 Foltz, I.N. et al. 1997. J. Biol. Chem. 272: 3296-3301.